Intranasal Immunization with a Formalin-Inactivated Human Influenza A Virus Whole-Virion Vaccine Alone and Intranasal Immunization with a Split-Virion Vaccine with Mucosal Adjuvants Show Similar Levels of Cross-Protection

The antigenicity of seasonal human influenza virus changes continuously; thus, a cross-protective influenza vaccine design needs to be established. Intranasal immunization with an influenza split-virion (SV) vaccine and a mucosal adjuvant induces cross-protection; however, no mucosal adjuvant has be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Okamoto, Shigefumi, Matsuoka, Sumiko, Takenaka, Nobuyuki, Haredy, Ahmad M., Tanimoto, Takeshi, Gomi, Yasuyuki, Ishikawa, Toyokazu, Akagi, Takami, Akashi, Mitsuru, Okuno, Yoshinobu, Mori, Yasuko, Yamanishi, Koichi
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2012
Matèries:
Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3393367/
https://ncbi.nlm.nih.gov/pubmed/22552600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00016-12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars